UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 214

Sortiert nach

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

European journal of cancer (1990), 2014-01, Vol.50 (1), p.78-84

2014

Link zum Volltext

Verfügbarkeit prüfen

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

Annals of oncology, 2012-11, Vol.23 (11), p.2943-2947

2012

Link zum Volltext

Verfügbarkeit prüfen

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

British journal of cancer, 2013-11, Vol.109 (10), p.2579-2586

2013

Link zum Volltext

Verfügbarkeit prüfen

A circulating miRNA signature to better stratify prostate cancer patients at diagnosis

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi21

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial outcomes in older patients with advanced solid tumours

British journal of cancer, 2016-02, Vol.114 (3), p.262-268

2016

Link zum Volltext

Verfügbarkeit prüfen

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies

Investigational new drugs, 2015-06, Vol.33 (3), p.679-690

2015

Link zum Volltext

Verfügbarkeit prüfen

Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis

Annals of oncology, 2018-10, Vol.29, p.viii282-viii282

2018

Link zum Volltext

Verfügbarkeit prüfen

Horizon scanning for novel therapeutics for the treatment of prostate cancer

Annals of oncology, 2010-10, Vol.21 (suppl-7), p.vii43-vii55

2010

Link zum Volltext

Verfügbarkeit prüfen

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

The New England journal of medicine, 2012-09, Vol.367 (13), p.1187-1197

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Molecular Determinants of Survival in Pancreatic Cancer Patients Treated with Second-line Chemotherapy: Results of an Italian/Swiss Multicenter Survey

Anticancer research, 2010-10, Vol.30 (10), p.4289-4295

2010

Link zum Volltext

Verfügbarkeit prüfen

31 Evaluating the antitumour activity of docetaxel following treatment with abiraterone acetate and steroids: Evidence for cross-resistance

Critical reviews in oncology/hematology, 2011, Vol.78, p.S23-S24

2011

Link zum Volltext

Verfügbarkeit prüfen

30 Weight change analysis in advanced castration resistant prostate cancer (CRPC) patients treated with Abiraterone Acetate (AA) single agent and in combination with steroids

Critical reviews in oncology/hematology, 2011, Vol.78, p.S23-S23

2011

Link zum Volltext

Verfügbarkeit prüfen

Correction: First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer

Clinical cancer research, 2015-02, Vol.21 (3), p.660-660

2015

Link zum Volltext

Verfügbarkeit prüfen

W Stands for Women: How the George W. Bush Presidency Shaped a New Politics of Gender

2007

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4577-4577

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II dose escalation study of sorafenib in patients with metastatic renal cell carcinoma (mRCC) who have had prior treatment with VEGFR-TKI antiangiogenic treatment

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16027-e16027

2009

Link zum Volltext

Verfügbarkeit prüfen

Dose finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e13534-e13534

2009

Link zum Volltext

Verfügbarkeit prüfen

814PPlatinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine (X) in elderly patients (pts) with hormone-refractory metastatic breast cancer (MBC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.1080-1080

2007

Link zum Volltext

Verfügbarkeit prüfen

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

Annals of oncology, 2012-11, Vol.23 (11), p.2943

2012

Link zum Volltext

Verfügbarkeit prüfen

Utilisation de l'ECT chez l'adolescent

Encéphale, 1990, Vol.16 (5), p.399-404

1990

Link zum Volltext

Verfügbarkeit prüfen

Conséquences psychopathologiques dune maladie cancéreuse dans la fratrie

Neuropsychiatrie de l'enfance et de l'adolescence, 1989, Vol.37 (8-9), p.411-414

1989

Link zum Volltext

Verfügbarkeit prüfen

Du divorce à la recomposition familiale

Journal de pédiatrie et de puériculture, 1994, Vol.7 (1), p.44-48

Zivi, A.

1994

Link zum Volltext

Verfügbarkeit prüfen

Les troubles psychiques chez l'enfant atteint d'une affection du systéme nerveux central

Neuropsychiatrie de l'enfance et de l'adolescence, 1989, Vol.37 (8-9), p.407-410

1989

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(179)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Humans
(57)
Life Sciences & Biomedicine
(54)
Male
(44)
Female
(32)
Technology
(28)
Aged
(24)
Middle Aged
(21)
Engineering
(19)
Oncology
(19)
Social Sciences
(19)
Adult
(16)
Engineering, Electrical & Electronic
(15)
Government & Law
(12)
Marine Vehicles
(12)
Political Science
(12)
Treatment Outcome
(12)
Aged, 80 And Over
(11)
Biological And Medical Sciences
(11)
Medical Sciences
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

A circulating miRNA signature to better stratify prostate cancer patients at diagnosis

Phase I trial outcomes in older patients with advanced solid tumours

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies

Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis

Horizon scanning for novel therapeutics for the treatment of prostate cancer

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Clinical and Molecular Determinants of Survival in Pancreatic Cancer Patients Treated with Second-line Chemotherapy: Results of an Italian/Swiss Multicenter Survey

31 Evaluating the antitumour activity of docetaxel following treatment with abiraterone acetate and steroids: Evidence for cross-resistance

30 Weight change analysis in advanced castration resistant prostate cancer (CRPC) patients treated with Abiraterone Acetate (AA) single agent and in combination with steroids

1785P Changes in bone mineral density, trabecular bone score and body composition in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to receive androgen deprivation + enzalutamide plus/minus zoledronic acid: The BonEnza study

Correction: First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer

W Stands for Women: How the George W. Bush Presidency Shaped a New Politics of Gender

An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome

Phase II dose escalation study of sorafenib in patients with metastatic renal cell carcinoma (mRCC) who have had prior treatment with VEGFR-TKI antiangiogenic treatment

Dose finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors

814PPlatinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis

Capecitabine (X) in elderly patients (pts) with hormone-refractory metastatic breast cancer (MBC)

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

Utilisation de l'ECT chez l'adolescent

Conséquences psychopathologiques dune maladie cancéreuse dans la fratrie

Du divorce à la recomposition familiale

Les troubles psychiques chez l'enfant atteint d'une affection du systéme nerveux central

Suchergebnisse filtern